"Move More" Exercise Program for Hemodialysis Patients
(Move More Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new exercise program for people undergoing hemodialysis, a treatment for kidney failure. It compares a personalized "Move More" exercise plan with a standard exercise routine used during dialysis sessions. The goal is to determine if "Move More" can increase activity levels, reduce fatigue, and improve overall well-being. Individuals who have been on hemodialysis for at least three months and are not already very active might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance the quality of life for those on hemodialysis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the "Move More" exercise program is safe for hemodialysis patients?
Research has shown that exercise programs during dialysis are generally safe. Patients often engage in activities like cycling or resistance exercises while receiving treatment. This setup allows for supervision, enhancing safety. However, specific safety information for the "Move More" program itself isn't detailed in the available studies.
The trial does not specify a particular phase, so there might be limited data on the safety of the "Move More" program. Nonetheless, other research has shown that exercise is well-tolerated by patients on hemodialysis. While specific reports of negative effects from "Move More" are absent, the program is designed to be personalized. This customization allows adjustments to fit each person's needs and abilities, which can help reduce risks.12345Why are researchers excited about this trial?
Researchers are excited about the "Move More" exercise program for hemodialysis patients because it introduces a personalized approach to increasing physical activity. Unlike traditional methods that might not cater to individual preferences or capabilities, this program allows participants to choose their own weekly exercise challenges, making it more engaging and adaptable. Additionally, the use of a point system based on metabolic equivalent (MET) scores encourages gradual and measurable increases in activity. This tailored strategy aims to improve not just physical health, but also quality of life for hemodialysis patients.
What evidence suggests that the "Move More" exercise program is effective for hemodialysis patients?
Research has shown that exercise programs can greatly improve physical abilities and quality of life for people on hemodialysis. Studies have found that structured exercise during dialysis sessions enhances physical function, exercise ability, and overall well-being. In this trial, participants may be assigned to the "Move More" program, a personalized, patient-focused approach designed to boost physical activity more effectively. This method has shown promise in improving physical performance and reducing tiredness and depression compared to standard exercise programs. Alternatively, participants might engage in an Intradialytic Exercise Program, which involves exercise during dialysis sessions. Additionally, programs like "Move More" can help manage blood pressure in hemodialysis patients. Overall, strong evidence supports the significant benefits of personalized exercise programs for those undergoing dialysis.23467
Who Is on the Research Team?
Kenneth R Wilud, PhD
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for hemodialysis patients who are looking to improve their physical activity levels and overall quality of life. The study will compare a standard exercise program with a personalized 'Move More' program tailored to individual needs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants undergo baseline testing and are randomly assigned to either the Move More or Intradialytic Exercise Program
Treatment
Participants engage in either the Move More personalized exercise program or the Intradialytic Exercise Program for 6 months
Follow-up
Participants are monitored for changes in physical activity levels, physical function, fatigue, and depressive symptoms
What Are the Treatments Tested in This Trial?
Interventions
- Move More
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor